These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 31280190)

  • 1. Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer.
    Maly V; Maly O; Kolostova K; Bobek V
    In Vivo; 2019; 33(4):1027-1037. PubMed ID: 31280190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring.
    Li W; Liu JB; Hou LK; Yu F; Zhang J; Wu W; Tang XM; Sun F; Lu HM; Deng J; Bai J; Li J; Wu CY; Lin QL; Lv ZW; Wang GR; Jiang GX; Ma YS; Fu D
    Mol Cancer; 2022 Jan; 21(1):25. PubMed ID: 35057806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cell detection may offer earlier diagnosis in patients suspected of asbestos-related lung cancer.
    Ke H; Kao S; van Zandwijk N; Rasko JEJ; Yeo D
    Lung Cancer; 2024 Jun; 192():107829. PubMed ID: 38810528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cells in patients with lung cancer: developments and applications for precision medicine.
    Tong B; Wang M
    Future Oncol; 2019 Jul; 15(21):2531-2542. PubMed ID: 31339062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of circulating tumor cells-from bench to bedside.
    Li Y; Wu S; Bai F
    Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Utility of Combined Circulating Tumor Cell and Circulating Tumor DNA Assays for Diagnosis of Primary Lung Cancer.
    Moon SM; Kim JH; Kim SK; Kim S; Kwon HJ; Bae JS; Lee S; Lee HS; Choi MY; Jeon BH; Jeong BH; Lee K; Kim HK; Kim J; Um SW
    Anticancer Res; 2020 Jun; 40(6):3435-3444. PubMed ID: 32487642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid Biopsy in Lung Cancer: Biomarkers for the Management of Recurrence and Metastasis.
    Souza VGP; Forder A; Brockley LJ; Pewarchuk ME; Telkar N; de Araújo RP; Trejo J; Benard K; Seneda AL; Minutentag IW; Erkan M; Stewart GL; Hasimoto EN; Garnis C; Lam WL; Martinez VD; Reis PP
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.
    Bracht JWP; Mayo-de-Las-Casas C; Berenguer J; Karachaliou N; Rosell R
    Curr Oncol Rep; 2018 Jul; 20(9):70. PubMed ID: 30030656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer.
    Li Y; Tian X; Gao L; Jiang X; Fu R; Zhang T; Ren T; Hu P; Wu Y; Zhao P; Yang D
    Cancer Med; 2019 Jul; 8(8):3782-3792. PubMed ID: 31132233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cells in breast cancer: applications in personalized medicine.
    Lee JS; Magbanua MJM; Park JW
    Breast Cancer Res Treat; 2016 Dec; 160(3):411-424. PubMed ID: 27761678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for detection of circulating cells in non-small cell lung cancer.
    Han Y; Su C; Liu Z
    Front Biosci (Landmark Ed); 2014 Jun; 19(6):896-903. PubMed ID: 24896324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma.
    Ahn JC; Teng PC; Chen PJ; Posadas E; Tseng HR; Lu SC; Yang JD
    Hepatology; 2021 Jan; 73(1):422-436. PubMed ID: 32017145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cells as a "real-time liquid biopsy": Recent advances and the application in ovarian cancer.
    Jou HJ; Ling PY; Hsu HT
    Taiwan J Obstet Gynecol; 2022 Jan; 61(1):34-39. PubMed ID: 35181043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells in the early detection of human cancers.
    Feng Z; Wu J; Lu Y; Chan YT; Zhang C; Wang D; Luo D; Huang Y; Feng Y; Wang N
    Int J Biol Sci; 2022; 18(8):3251-3265. PubMed ID: 35637960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.
    O'Flaherty JD; Gray S; Richard D; Fennell D; O'Leary JJ; Blackhall FH; O'Byrne KJ
    Lung Cancer; 2012 Apr; 76(1):19-25. PubMed ID: 22209049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation.
    Ren F; Fei Q; Qiu K; Zhang Y; Zhang H; Sun L
    J Exp Clin Cancer Res; 2024 Apr; 43(1):96. PubMed ID: 38561776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer.
    Cortés-Hernández LE; Eslami-S Z; Alix-Panabières C
    Mol Aspects Med; 2020 Apr; 72():100816. PubMed ID: 31377345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Tumor Cells: State-of-the-art Update on Technologies and Clinical Applications.
    Yap K; Cohen EN; Reuben JM; Khoury JD
    Curr Hematol Malig Rep; 2019 Oct; 14(5):353-357. PubMed ID: 31364034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-Cell Lung Cancer: Is Liquid Biopsy a New Tool Able to Predict the Efficacy of Immunotherapy?
    Fasano R; Serratì S; Rafaschieri T; Longo V; Di Fonte R; Porcelli L; Azzariti A
    Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsy in lung cancer management.
    Irofei Zamfir MA; Buburuzan L; Hudiţă A; Gălăţeanu B; Ginghină O; Ion D; Motaş N; Ardeleanu CM; Costache M
    Rom J Morphol Embryol; 2022; 63(1):31-38. PubMed ID: 36074665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.